Subscribe To Our Free Newsletter |
Aurobindo Pharma gets USFDA nod for Risedronate Sodium Tablets
The pharma company has received final approval from the US Food & Drug Administration to manufacture and market Risedronate Sodium Tablets USP, 5 mg, 30 mg and 35 mg.